UnknownNot Applicable

Intensive Trauma Treatment for Children Exposed to Parental Conflict

United States4 participantsStarted 2015-02

Plain-language summary

The purpose of this study is to track outcomes of the investigator's therapy approach with children of separation/divorce who have been exposed to parental conflict.

Who can participate

Age range

6 Years – 16 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * child between the ages of 6 - 16 * parent concerned re child's distress and behaviors related to custody, visitation, etc. * parent has the legal authority to obtain treatment for the child * parent and child fluent in English Exclusion Criteria: * as per clinical judgment of the PI during a telephone screening (interview of the referring parent), determination that the child is unlikely to be responsive to the intensive therapy format. This would typically be due to the child having a severe intellectual impairment, major dissociative disorder, etc.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in CROPS following treatment

Timeframe: Pre-treatment, 2 weeks post-treatment, 2 months post-treatment

Change in PROPS following treatment

Timeframe: Pre-treatment, 2 weeks post-treatment, 2 months post-treatment

Change in SUDS following treatment

Timeframe: Pre-treatment, 2 weeks post-treatment, 2 months post-treatment

Change in PRS following treatment

Timeframe: Pre-treatment, 2 weeks post-treatment, 2 months post-treatment

Trial details

NCT IDNCT03271346

SponsorTrauma Institute & Child Trauma Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-01-30

Contact for this trial

Ricky Greenwald, PsyD

413-774-2340 cti@childtrauma.com

View on ClinicalTrials.gov More Conflict, Interparental trials

Who can participate

Age range

6 Years – 16 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in CROPS following treatment

Timeframe: Pre-treatment, 2 weeks post-treatment, 2 months post-treatment

Change in PROPS following treatment

Timeframe: Pre-treatment, 2 weeks post-treatment, 2 months post-treatment

Change in SUDS following treatment

Timeframe: Pre-treatment, 2 weeks post-treatment, 2 months post-treatment

Change in PRS following treatment

Timeframe: Pre-treatment, 2 weeks post-treatment, 2 months post-treatment